GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MegaPro Biomedical Co Ltd (ROCO:6827) » Definitions » Loans Receivable

MegaPro Biomedical Co (ROCO:6827) Loans Receivable : NT$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MegaPro Biomedical Co Loans Receivable?

MegaPro Biomedical Co's Loans Receivable for the quarter that ended in Dec. 2024 was NT$0.00 Mil.


MegaPro Biomedical Co Loans Receivable Historical Data

The historical data trend for MegaPro Biomedical Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MegaPro Biomedical Co Loans Receivable Chart

MegaPro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Loans Receivable
Get a 7-Day Free Trial - - - - -

MegaPro Biomedical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MegaPro Biomedical Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


MegaPro Biomedical Co Loans Receivable Related Terms

Thank you for viewing the detailed overview of MegaPro Biomedical Co's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


MegaPro Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 66, Shengyi 5th Road, 10F-1, Hsinchu Science Park, Hsinchu, TWN, 31040
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.

MegaPro Biomedical Co Headlines

No Headlines